Veradigm | MDRX - Market Capitalization


Veradigm reported $542M in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alcidion AUD 141.01M 6.71M Dec/2025
Ambu A/S DKK 18.42B 15.28B Mar/2026
Cardinal Health USD 49.72B 894M Mar/2026
Centene USD 16.17B 4.06B Mar/2026
Charles River Laboratories USD 7.85B 2.17B Mar/2026
Cigna USD 70.33B 3.19B Mar/2026
Coloplast 124.69B 775.88M Dec/2025
CVS Health USD 92.04B 8.7B Mar/2026
Diasorin EUR 3.36B 483.39M Mar/2026
Elevance Health USD 64.31B 13.6B Mar/2026
General Electric Aerospace USD 296.49B 28.42B Mar/2026
Gulf Medical Proj AED 1.36B 167.74M Dec/2025
Humana USD 20.82B 9.99B Mar/2026
IQVIA Holdings USD 28.63B 9.76B Mar/2026
Laboratory Of America USD 21.93B 1.13B Mar/2026
Maximus USD 3.5B 1.2B Mar/2026
McKesson USD 106B 4.75B Mar/2026
Med Life RON 4.16B 601.5M Sep/2025
Molina Healthcare USD 6.94B 1.98B Mar/2026
Omnicell USD 1.52B 515M Mar/2026
Oriola-kd EUR 213.12M 0 Dec/2025
Owens Minor USD 217M 154M Dec/2025
Quest Diagnostics USD 21.69B 2.39B Mar/2026
Rede D'or Sao Luiz BRL 89.21B 3.75B Mar/2026
Siemens Healthineers EUR 40.95B 9.72B Mar/2026
UnitedHealth USD 245.61B 53.42B Mar/2026
Veeva Systems USD 28.83B 3.38B Jun/2026
Veradigm USD 525M 621M Mar/2026